Literature DB >> 24412296

Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant intravenous eribulin.

Sabrina Salgia1, Gini F Fleming2, Rimas V Lukas3.   

Abstract

We present a patient with leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan and intravenous eribulin. The regimen was well tolerated and provided clinical stability in a patient with progression on a prior intrathecal chemotherapy regimen.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast neoplasms; Eribulin; Intrathecal; Meningeal carcinomatosis; Topotecan

Mesh：

Substances：

Year:  2013        PMID： 24412296     DOI： 10.1016/j.jocn.2013.09.018

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN： 0967-5868            Impact factor:   1.961


  3 in total

1.  Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance.

Authors:  Inna Smalley; Vincent Law; Clayton Wyatt; Brittany Evernden; Bin Fang; John M Koomen; Eric A Welsh; Robert J B Macaulay; Peter A Forsyth; Keiran S M Smalley
Journal:  Clin Cancer Res       Date:  2020-01-10       Impact factor: 12.531

Review 2.  Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.

Authors:  Keiran S M Smalley; Inna V Fedorenko; Rajappa S Kenchappa; Solmaz Sahebjam; Peter A Forsyth
Journal:  Int J Cancer       Date:  2016-04-30       Impact factor: 7.396

3.  Intrathecal Methotrexate and Craniospinal Radiotherapy Can Be an Effective Treatment of Carcinomatous Meningitis in Patients with Breast Cancer: Case Reports.

Authors:  Magdalena Meissner; Alfredo Addeo
Journal:  Case Rep Oncol       Date:  2016-10-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.